ea0037ep1337 | Clinical Cases–Thyroid/Other | ECE2015
Dineen Rosemary
, Pazderska Agnieszka
, Mullan Ronan
, Gibney James
, Sherlock Mark
Cyclophosphamide is an alkylating agent used in the treatment of malignant and autoimmune diseases. Severe hyponatraemia is a serious electrolyte disorder with life threatening neurological sequelae. We report a case of recurrent severe, symptomatic hyponatraemia that developed in a 61 year old female with systemic vasculitis and Sjogrens syndrome following low-dose cyclophosphamide.Case report: A 61 year old lady, with ANA positive systemic vasculitis p...